Purpose Acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)
primarily afflict older individuals. Hematopoietic cell transplantation (HCT) is generally not …

Reduced-intensity conditioning (RIC) allows for the use of allogeneic hematopoietic stem
cell transplantation (HSCT) in older patients with acute myelogenous leukemia (AML). We …

We compared the outcomes of patients age 60-70 years with acute myelogenous leukemia
receiving reduced-intensity allogeneic hematopoietic cell transplantation (HCT) in first …

Purpose Long-term survival rates for older patients with newly diagnosed acute myeloid
leukemia (AML) are extremely low. Previous observational studies suggest that allogeneic …

The benefits of allogeneic hematopoietic cell transplantation (allo-HCT) for patients with
acute myelogenous leukemia (AML) in first complete remission (CR1) have mostly been …

Results of reduced intensity conditioning regimen (RIC) in the HLA identical haematopoietic
stem cell transplantation (HSCT) setting have not been compared to those after …

Background Acute myeloid leukaemia mainly affects elderly people, with a median age at
diagnosis of around 70 years. Although about 50–60% of patients enter first complete …

To prospectively assess the applicability of reduced-intensity conditioning hematopoietic
stem cell transplantation (RIC-HSCT), we wrote a protocol in which all untreated patients 50 …

Acute myeloid leukemia is the most common indication for an allogeneic hematopoietic cell
transplant. The introduction of reduced intensity conditioning has expanded the recipient …

The preferred post-remission therapy for older patients with acute myeloid leukemia (AML)
in first complete remission (CR1) remains uncertain. In this retrospective, multicenter study …